Q3 2020 Sales Performance

Vaccines Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries. £7.2bn, +19% CER Sales turnover 2019 Key Products Shingrix Shingles Infanrix/Pediarix Paediatric Bexsero, Menveo Meningitis Herpes zoster virus of shingles

View entire presentation